Gossamer Bio, Inc.
We are a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology.
$16.00 - $16.00
February 8, 2019
BofA Merrill Lynch, Leerink Partners, Barclays, Evercore ISI
To view the prospectus for Gossamer Bio, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277